OMER – omeros corporation (US:NASDAQ)
Stock Stats
News
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros' Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906) [Yahoo! Finance]
Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)
Omeros: Key Milestone Ahead, Risk-Averse Investors Should Avoid [Seeking Alpha]
Omeros Corporation (OMER) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Form 8-K OMEROS CORP For: Nov 25
Form 424B5 OMEROS CORP
Form S-3ASR OMEROS CORP
Form SCHEDULE 13G/A OMEROS CORP Filed by: VANGUARD GROUP INC
Form 4 OMEROS CORP For: Oct 13 Filed by: Demopulos Gregory A MD
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.